These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 15958775

  • 1. Systemic sclerosis in Europe: first report from the EULAR Scleroderma Trials And Research (EUSTAR) group database.
    Tyndall A, Mueller-Ladner U, Matucci-Cerinic M.
    Ann Rheum Dis; 2005 Jul; 64(7):1107. PubMed ID: 15958775
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Ten years EULAR Scleroderma Research and Trials (EUSTAR): what has been achieved?
    Müller-Ladner U, Tyndall A, Czirjak L, Denton C, Matucci-Cerinic M, EUSTAR centres.
    Ann Rheum Dis; 2014 Feb; 73(2):324-7. PubMed ID: 24121165
    [Abstract] [Full Text] [Related]

  • 4. Geographical variation of disease manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research (EUSTAR) group database.
    Walker UA, Tyndall A, Czirják L, Denton CP, Farge-Bancel D, Kowal-Bielecka O, Müller-Ladner U, Matucci-Cerinic M, EUSTAR co-authors.
    Ann Rheum Dis; 2009 Jun; 68(6):856-62. PubMed ID: 18625615
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical correlations of hypocomplementaemia in systemic sclerosis: an analysis of the EULAR Scleroderma Trial and Research group (EUSTAR) database.
    Foocharoen C, Distler O, Becker M, Müller-Ladner U, von Mühlen C, Leuchten N, Walker UA.
    Scand J Rheumatol; 2012 May; 41(3):243-6. PubMed ID: 22309107
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. How can treatment of systemic sclerosis be improved?. By setting up a national database of all cases and entering patients into trials. UK Scleroderma Study Group.
    UK Scleroderma Study Groupc/o Carol Black, Royal Free Academic Unit of Rheumatology and Connective Tissue Diseases, London NW3 2PF.
    BMJ; 1998 Aug 01; 317(7154):294-5. PubMed ID: 9685270
    [No Abstract] [Full Text] [Related]

  • 13. EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma research.
    Beyer C, Distler JH, Allanore Y, Aringer M, Avouac J, Czirják L, Cutolo M, Damjanov N, Del Galdo F, Fligelstone K, Guiducci S, Kowal-Bielecka O, van Laar JM, Martucci-Cerinic M, Müller-Ladner U, Riemekasten G, Tarner IH, Tyndall A, Kennedy AT, Valentini G, Vettori S, Walker UA, Denton C, Distler O, EUSTAR Biobanking Group.
    Ann Rheum Dis; 2011 Jul 01; 70(7):1178-82. PubMed ID: 21285118
    [Abstract] [Full Text] [Related]

  • 14. Evidence-based management of systemic sclerosis: Navigating recommendations and guidelines.
    Pellar RE, Pope JE.
    Semin Arthritis Rheum; 2017 Jun 01; 46(6):767-774. PubMed ID: 28088339
    [Abstract] [Full Text] [Related]

  • 15. The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy.
    Matucci-Cerinic M, Allanore Y, Czirják L, Tyndall A, Müller-Ladner U, Denton C, Valentini G, Distler O, Fligelstone K, Tyrrel-Kennedy A, Farge D, Kowal-Bielecka O, van den Hoogen F, Cutolo M, Sampaio-Barros PD, Nash P, Takehara K, Furst DE.
    Ann Rheum Dis; 2009 Sep 01; 68(9):1377-80. PubMed ID: 19674983
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Towards an implementation of guidelines for the therapy of systemic sclerosis (scleroderma): between desire and reality].
    Becker MO, Müller-Ladner U, Riemekasten G.
    Z Rheumatol; 2010 Jun 01; 69(4):310-7. PubMed ID: 20490516
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.